Chronic Disease Health Management Information Platform

The Construction and Empirical Research of Hospital Chronic Disease Health Management Information Platform From the Perspective of Internet

Based on the combination of domestic and foreign experience and the needs of patients as the orientation, this research gives full play to the hospital's advantages in chronic disease management, and uses network information technology to develop a systematic and intelligent system that integrates prevention, diagnosis and treatment, follow-up, and education.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

Patients with hypertension are showing a trend of getting younger and younger, and high-normal blood pressure is increasing rapidly among the young and middle-aged people aged less than 65 years.

Young and middle-aged patients with hypertension have a lower absolute short-term cardiovascular risk, but their lifetime risk is higher.

Studies have shown that the awareness rate, treatment rate and control rate ("three rates") of young and middle-aged hypertensive patients in my country need to be improved urgently.

Improving the knowledge and behavior of young and middle-aged hypertensive patients with disease, treatment compliance and self-health management has become the focus of research.

"Internet + medical" through information network technology, innovative service models have become a trend.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310009
        • Outpatient Department of the Second Affiliated Hospital of Zhejiang University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Young and middle-aged patients with essential hypertension in the Cardiovascular Outpatient Department of a tertiary A general hospital

Description

Inclusion Criteria:

  • Patients who are 18 to 59 years old according to the World Health Organization (WHO) age classification criteria, meet the diagnostic criteria for hypertension published in the "Guidelines for the Prevention and Control of Hypertension in China", and are diagnosed with essential hypertension;
  • Patients are conscious and possess Normal reading, comprehension and expression skills;
  • use a smart phone to surf the Internet and send and receive information, accept and use the outpatient chronic disease health management platform services;
  • Informed consent, voluntarily participate in this research.

Exclusion Criteria:

  • Patients with severe organic heart disease and other cardiovascular and cerebrovascular diseases;
  • Chronic liver and kidney failure;
  • Patients with malignant tumors;
  • Persons who have participated in other forms of Internet + health management.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health literacy level
Time Frame: 1 YEAR
The individual's ability to acquire, understand, evaluate and exchange information in different environments throughout the life process to improve, maintain and improve health
1 YEAR
Self-management behavior ability
Time Frame: 1 YEAR
The self-management behavior assessment scale for hypertensive patients includes six dimensions of medication management, condition monitoring, diet management, exercise management, rest and work management, and emotional management, as well as the assessment of the total level of self-management. There are 33 items in total, the sum of the scores of each item For the final total score of the scale, the items use Likert 5-level scoring method, which is always (5 points), often (4 points), sometimes (3 points), rarely (2 points), never (1 point).
1 YEAR
Blood pressure compliance rate
Time Frame: 1 YEAR
The "Guidelines for the Prevention and Treatment of Hypertension in China (2018 Revised Edition)" recommends that blood pressure be reduced to <140/90 mmHg. In this study, the blood pressure compliance rate means that the patient's blood pressure measurement value is less than 140/90mmHg and stable for more than one month. Blood pressure compliance rate = number of people meeting blood pressure/total number of people receiving chronic disease management in outpatient clinics * 100%.
1 YEAR

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: FANG LIANGYU, Outpatient Department of the Second Affiliated Hospital of Zhejiang University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Anticipated)

September 1, 2021

Study Completion (Anticipated)

December 1, 2021

Study Registration Dates

First Submitted

December 3, 2020

First Submitted That Met QC Criteria

January 17, 2021

First Posted (Actual)

January 22, 2021

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 13, 2023

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2020-701

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Online education

Subscribe